Abstract
With the advent of new oral anticoagulants (NOACs), it is a challenge for a plastic surgeon to stay updated with the myriad of new medications, and their associated mechanisms of action, laboratory monitoring, adverse events and potential reversal agents. The limitations of warfarin therapy include varying pharmacokinetic profiles, multitude of food and drug interactions, hypersensitivity, resistance, therapy failure and frequent laboratory monitoring)1. Hence there are an increasing number of patients who are presenting to their plastic surgeon on alterative antithrombotic agents. The aim of this paper is to educate Plastic Surgeons regarding NOAC's, and their management in the operative setting.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
